Smoking cessation in patients with established coronary artery disease: data from the POLASPIRE survey

Abstract

This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives 4.0 International License (CC BY-NC-ND 4.0), allowing third parties to download articles and share them with others, provided the original work is properly cited, not changed in any way, distributed under the same license, and used for noncommercial purposes only.

Smoking cessation after coronary angiography and percutaneous coronary intervention

“…Repeated hospitalization as a determinant of SC may be attributed to the same problem of CAD extension. Rehabilitation following a cardiovascular event was related to a higher likelihood of SC in the POLASPIRE study (26). In our study, SC occurred more frequently among patients who participated in a rehabilitation programme in univariable analysis, but this finding was not confirmed in multivariable analysis.…”

“…Pharmacotherapy significantly increases the rate of SC, but it is rarely implemented in clinical settings [26,27]. Only 64 (26.5%) patients in the present study used any form of pharmacological smoking aid.…”

“…In a study of patients after AMI at a young age and with high intensity of smoking, preceding MI due to smoking was associated with a higher risk of persistent smoking [24]. In the study of the Polish population, Koziel et al identified older age as a factor linked to a higher likelihood of SC [26]; but a longer duration of smoking was linked to a lower possibility of SC in the same study. In the EUROASPIRE IV study, Snaterse et al reported that increasing age was linked to a higher chance of SC (OR: 1.50; 95% CI: 1.09-2.06) [13].…”

Dyslipidemia Management in Patients with Coronary Artery Disease. Data from the POLASPIRE Survey

“…We looked at a measure of loneliness by including the question: "Do you have somebody with whom you share your problems or happiness?". We constructed a socio-economic status (SES) summary score based on the different socio-economic components [23]. This score was the sum of the following sub-scores: educational level (primary school completed or less = 0, intermediate = 2, college/university = 4); perceived income (very low = 0, low = 2, intermediate = 4, high = 6); loneliness (yes = 0, no = 2); employment (yes = 2, no = 0); and being married (yes = 1, no = 0).…”

Is cytisine contraindicated in smoking patients with coronary artery disease after percutaneous coronary intervention?

“…Cardiovascular diseases are the most common cause of death among cigarette smokers [1]; thus, smoking cessation, an effective lifestyle intervention [2], is crucial for primary and secondary prevention of coronary artery disease (CAD). Pharmacotherapy for smoking cessation significantly increases the rate of smoking cessation, but it is rarely implemented in clinical settings [3,4]. First-line pharmacotherapies with nicotine replacement therapy (NRT), varenicline or bupropion, are the recommended course of action for smoking cessation [5].…”